Since the initial proposal was developed in 2004, the road to expansion for the University of Ottawa Heart Institute has been a long one. The Province of Ontario announcement in August 2011 of funding to expand and update facilities at the Heart Institute had been greatly anticipated. Since the

Few health challenges are as well-publicized as high blood pressure, a topic that has become all too familiar, appearing everywhere from the daily news to medical conferences. And being so familiar, it is easy to overlook the fact that most of this attention has been devoted to a problem that stems

Like most health care organizations in Canada, the University of Ottawa Heart Institute undergoes regular review by Accreditation Canada. This rigorous process assesses hospitals against more than 900 standards and criteria. As part of its 2013 accreditation, Accreditation Canada identified four

This year, the Canadian Cardiovascular Congress is part of an even larger event called Vascular 2013, combining parallel conferences dedicated to cardiovascular disease, hypertension, diabetes and stroke. The University of Ottawa Heart Institute has program items in all of these—nearly 120 in all

In July, the first patient in a landmark clinical trial received treatment at the University of Ottawa Heart Institute. The new ENACT-AMI (Enhanced Angiogenic Cell Therapy—Acute Myocardial Infarction) trial, led by the Ottawa Hospital Research Institute, is designed to test whether genetically

This year, the Canadian Cardiovascular Congress (CCC) was part of an even larger event called Vascular 2013 that added parallel conferences dedicated to hypertension, diabetes and stroke. The University of Ottawa Heart Institute had program items in all of these subject areas— nearly 120 in all